Advances in kidney transplant immunosuppression: Emerging biologics

Academic Article


  • There remains a need in solid-organ transplantation for an immunosuppressive agent with a novel mechanism of action and fewer adverse consequences to replace current immunosuppressive drugs and improve long-term patient and graft survival. There are several agents on the horizon, both small molecules and biologics, offering this promise along with ease and consistency of long-term administration. We discuss three biologic agents currently in advanced stages of clinical trials in kidney transplantation. Copyright © 2011 Wiley Periodicals, Inc.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Kumar V; Gaston RS
  • Start Page

  • 30
  • End Page

  • 32
  • Volume

  • 40
  • Issue

  • 1